The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
Breast cancer is one of the most-researched illnesses in the world. But some men suffering from the disease say they’re not able to benefit from new research and treatments.
Recent health developments include the EU backing Novo Nordisk's Wegovy for obesity-related heart conditions, FDA approvals ...
AstraZeneca has announced that FluMist has been approved in the US as the self-administered influenza vaccine. FluMist, a ...
A pill Novo acquired produced modest weight loss but raised safety questions. Elsewhere, Sanofi detailed the silver lining it found in a recent study and a heart drug developer’s shares surged.
Key Insights ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
The FDA Friday approved the flu vaccine that can be done at home and does not need to be administered by a health care provider.
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...
The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback